TRACON Pharmaceuticals Price History

TCONDelisted Stock  USD 1.60  0.55  52.38%   
If you're considering investing in TRACON Stock, it is important to understand the factors that can impact its price. As of today, the current price of TRACON Pharmaceuticals stands at 1.60, as last reported on the 3rd of December, with the highest price reaching 1.71 and the lowest price hitting 0.85 during the day. We have found twenty-three technical indicators for TRACON Pharmaceuticals, which you can use to evaluate the volatility of the company. Please validate TRACON Pharmaceuticals' risk adjusted performance of (0.12), and Standard Deviation of 11.21 to confirm if the risk estimate we provide is consistent with the expected return of 0.0%.
  
TRACON Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = 0.0

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
TCON
Based on monthly moving average TRACON Pharmaceuticals is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of TRACON Pharmaceuticals by adding TRACON Pharmaceuticals to a well-diversified portfolio.

TRACON Pharmaceuticals Stock Price History Chart

There are several ways to analyze TRACON Stock price data. The simplest method is using a basic TRACON candlestick price chart, which shows TRACON Pharmaceuticals price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.

TRACON Stock Price History Data

The price series of TRACON Pharmaceuticals for the period between Wed, Sep 4, 2024 and Tue, Dec 3, 2024 has a statistical range of 7.63 with a coefficient of variation of 83.0. The price distribution for the period has arithmetic mean of 2.34. The median price for the last 90 days is 1.73. The company completed stock split (1:20) on 10th of April 2024. TRACON Pharmaceuticals had dividends distributed to its stock-holders on 2019-11-08.
OpenHighLowCloseVolume
12/03/2024
 1.05  1.71  0.85  1.60 
06/28/2024 1.05  1.71  0.85  1.60  367,866 
06/27/2024 1.45  1.77  1.41  1.43  498,931 
06/26/2024 1.40  1.54  1.40  1.45  86,187 
06/25/2024 1.21  1.55  1.21  1.49  258,589 
06/24/2024 1.22  1.30  1.15  1.23  121,007 
06/21/2024 1.22  1.30  1.20  1.25  80,521 
06/20/2024 1.27  1.33  1.21  1.23  67,667 
06/18/2024 1.34  1.40  1.26  1.29  78,871 
06/17/2024 1.28  1.35  1.22  1.34  278,526 
06/14/2024 0.97  1.48  0.93  1.26  745,977 
06/13/2024 1.00  1.00  0.85  0.97  161,732 
06/12/2024 0.69  1.01  0.66  1.00  1,114,970 
06/11/2024 1.10  1.12  1.03  1.08  154,652 
06/10/2024 1.13  1.13  1.06  1.08  45,490 
06/07/2024 1.16  1.24  1.10  1.14  84,830 
06/06/2024 1.22  1.23  1.14  1.18  66,262 
06/05/2024 1.30  1.30  1.20  1.22  78,070 
06/04/2024 1.36  1.36  1.21  1.25  72,346 
06/03/2024 1.28  1.38  1.24  1.27  101,485 
05/31/2024 1.32  1.33  1.26  1.28  46,453 
05/30/2024 1.49  1.50  1.21  1.25  271,139 
05/29/2024 1.52  1.52  1.48  1.51  78,603 
05/28/2024 1.49  1.53  1.48  1.50  35,542 
05/24/2024 1.53  1.54  1.48  1.49  56,465 
05/23/2024 1.49  1.57  1.49  1.52  122,904 
05/22/2024 1.52  1.55  1.47  1.50  51,377 
05/21/2024 1.48  1.49  1.42  1.49  49,067 
05/20/2024 1.42  1.52  1.41  1.44  83,729 
05/17/2024 1.58  1.58  1.42  1.43  119,558 
05/16/2024 1.62  1.68  1.52  1.53  108,043 
05/15/2024 1.60  1.70  1.52  1.62  206,969 
05/14/2024 2.02  2.06  1.95  1.97  169,230 
05/13/2024 2.00  2.05  1.91  2.02  150,481 
05/10/2024 1.82  2.05  1.80  1.93  451,307 
05/09/2024 1.75  1.83  1.72  1.83  132,599 
05/08/2024 1.81  1.84  1.71  1.76  114,186 
05/07/2024 1.83  1.84  1.74  1.82  90,880 
05/06/2024 1.88  1.92  1.77  1.81  107,223 
05/03/2024 1.82  1.94  1.80  1.86  261,679 
05/02/2024 1.72  1.87  1.72  1.81  149,415 
05/01/2024 1.69  1.85  1.69  1.71  192,431 
04/30/2024 1.90  1.95  1.70  1.73  191,248 
04/29/2024 1.83  2.10  1.81  1.87  243,873 
04/26/2024 1.77  1.88  1.70  1.81  206,653 
04/25/2024 1.88  1.97  1.76  1.79  131,052 
04/24/2024 1.83  1.94  1.83  1.89  65,903 
04/23/2024 1.82  1.96  1.82  1.85  55,123 
04/22/2024 1.91  1.94  1.70  1.82  143,958 
04/19/2024 2.12  2.14  1.93  1.96  250,528 
04/18/2024 2.09  2.34  2.06  2.11  359,977 
04/17/2024 1.71  2.89  1.71  2.29  2,023,692 
04/16/2024 1.80  1.93  1.59  1.71  264,946 
04/15/2024 2.15  2.28  1.72  1.80  254,190 
04/12/2024 2.61  2.65  2.25  2.36  344,803 
04/11/2024 3.10  3.37  2.55  2.59  214,586 
04/10/2024 3.01  3.15  2.70  3.01  285,269 
04/09/2024 3.84  4.08  3.03  3.36  208,627 
04/08/2024 4.84  5.00  3.70  3.84  346,573 
04/05/2024 5.20  5.40  4.60  5.11  94,437 
04/04/2024 4.60  5.58  4.52  5.25  431,624 

About TRACON Pharmaceuticals Stock history

TRACON Pharmaceuticals investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for TRACON is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in TRACON Pharmaceuticals will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing TRACON Pharmaceuticals stock prices may prove useful in developing a viable investing in TRACON Pharmaceuticals
TRACON Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics for cancer in the United States. TRACON Pharmaceuticals, Inc. was incorporated in 2004 and is headquartered in San Diego, California. Tracon Pharma operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 19 people.

TRACON Pharmaceuticals Stock Technical Analysis

TRACON Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, delisted stock market cycles, or different charting patterns.
A focus of TRACON Pharmaceuticals technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of TRACON Pharmaceuticals trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Did you try this?

Run Idea Breakdown Now

   

Idea Breakdown

Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
All  Next Launch Module

TRACON Pharmaceuticals Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for TRACON Pharmaceuticals' price direction in advance. Along with the technical and fundamental analysis of TRACON Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of TRACON to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.
You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.

Other Consideration for investing in TRACON Stock

If you are still planning to invest in TRACON Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the TRACON Pharmaceuticals' history and understand the potential risks before investing.
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume